BRD4 and nonpapillary renal cell carcinoma: Therefore, in this study, we aimed to investigate the anti-cancer efficiency of JQ1 in vitro and in vivo and to elucidate the molecular mechanisms underlying BRD4 inhibition in sunitinib-sensitive and -resistant ccRCC.